BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21695203)

  • 1. Viral shedding in patients infected with pandemic influenza A (H1N1) virus in Kenya, 2009.
    Waiboci LW; Lebo E; Williamson JM; Mwiti W; Kikwai GK; Njuguna H; Olack B; Breiman RF; Njenga MK; Katz MA
    PLoS One; 2011; 6(6):e20320. PubMed ID: 21695203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral shedding duration of pandemic influenza A H1N1 virus during an elementary school outbreak--Pennsylvania, May-June 2009.
    Bhattarai A; Villanueva J; Palekar RS; Fagan R; Sessions W; Winter J; Berman L; Lute J; Leap R; Marchbanks T; Sodha SV; Moll M; Xu X; Fry A; Fiore A; Ostroff S; Swerdlow DL;
    Clin Infect Dis; 2011 Jan; 52 Suppl 1():S102-8. PubMed ID: 21342880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed oseltamivir treatment is associated with longer viral shedding of pandemic (H1N1) 2009 virus.
    Leung YH; Lim WL; Wong MH; Chuang SK
    Epidemiol Infect; 2012 May; 140(5):814-7. PubMed ID: 21801465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral load in patients infected with pandemic H1N1 2009 influenza A virus.
    To KK; Chan KH; Li IW; Tsang TY; Tse H; Chan JF; Hung IF; Lai ST; Leung CW; Kwan YW; Lau YL; Ng TK; Cheng VC; Peiris JS; Yuen KY
    J Med Virol; 2010 Jan; 82(1):1-7. PubMed ID: 19950247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the viral distribution pattern after the appearance of the novel influenza A H1N1 (pH1N1) virus in influenza-like illness patients in Peru.
    Laguna-Torres VA; Gómez J; Aguilar PV; Ampuero JS; Munayco C; Ocaña V; Pérez J; Gamero ME; Arrasco JC; Paz I; Chávez E; Cruz R; Chavez J; Mendocilla S; Gomez E; Antigoni J; Gonzalez S; Tejada C; Chowell G; Kochel TJ;
    PLoS One; 2010 Jul; 5(7):e11719. PubMed ID: 20668548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors promoting the prolonged shedding of the pandemic (H1N1) 2009 influenza virus in patients treated with oseltamivir for 5 days.
    Ryoo SM; Kim WY; Sohn CH; Seo DW; Oh BJ; Lee JH; Lee YS; Lim KS
    Influenza Other Respir Viruses; 2013 Sep; 7(5):833-7. PubMed ID: 23279949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial.
    Fry AM; Goswami D; Nahar K; Sharmin AT; Rahman M; Gubareva L; Azim T; Bresee J; Luby SP; Brooks WA
    Lancet Infect Dis; 2014 Feb; 14(2):109-18. PubMed ID: 24268590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pandemic (H1N1) 2009 virus infection: persistent viral shedding after Oseltamivir treatment.
    Kanchana S; Kanchana S; Chuntrakul C; Malathum K; Prachayangprecha S; Poovorawan Y
    J Infect; 2011 Oct; 63(4):295-9. PubMed ID: 21840339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization and phylogenetic analysis of the hemagglutinin 1 protein of human influenza A virus subtype H1N1 circulating in Kenya during 2007-2008.
    Bulimo WD; Achilla RA; Majanja J; Mukunzi S; Wadegu M; Osunna F; Mwangi J; Njiri J; Wangui J; Nyambura J; Obura B; Mitei K; Omariba D; Segecha S; Nderitu M; Odindo A; Adega C; Kiponda J; Mupa R; Munyazi F; Kissinger G; Mwakuzimu M; Kamola D; Muhidin E; Kamau D; Kairithia S; Koech M; Sang A; Onge'ta L; Schnabel DC
    J Infect Dis; 2012 Dec; 206 Suppl 1():S46-52. PubMed ID: 23169971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virus detection and duration of illness among patients with 2009 pandemic influenza A (H1N1) virus infection in Texas.
    Suryaprasad A; Morgan OW; Peebles P; Warner A; Kerin TK; Esona MD; Bowen MD; Sessions W; Xu X; Cromeans T; Dawood F; Shim T; Menon M; Verani JR; Erdman D; Lindstrom S; Fonseca VP; Fry AM; Olsen SJ
    Clin Infect Dis; 2011 Jan; 52 Suppl 1():S109-15. PubMed ID: 21342881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China.
    Cao B; Li XW; Mao Y; Wang J; Lu HZ; Chen YS; Liang ZA; Liang L; Zhang SJ; Zhang B; Gu L; Lu LH; Wang DY; Wang C;
    N Engl J Med; 2009 Dec; 361(26):2507-17. PubMed ID: 20007555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection.
    Ling LM; Chow AL; Lye DC; Tan AS; Krishnan P; Cui L; Win NN; Chan M; Lim PL; Lee CC; Leo YS
    Clin Infect Dis; 2010 Apr; 50(7):963-9. PubMed ID: 20180701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of 1 dose of influenza A (H1N1) 2009 monovalent vaccines in preventing reverse-transcription polymerase chain reaction-confirmed H1N1 infection among school-aged children in maine.
    Uzicanin A; Thompson M; Smith P; Chaves SS; Foster L; Dube N; Graitcer S; Jackson R; Ferdinands J; Gargiullo P; Mills D; Monto AS; Shay DK;
    J Infect Dis; 2012 Oct; 206(7):1059-68. PubMed ID: 22850120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration of viral shedding in patients admitted to hospital with pandemic influenza A/H1N1 2009 infection.
    Na S; Chong YP; Kim MN; Kim WY; Kim W; Hong SB; Lim CM; Koh Y; Kwon JW; Hong SJ; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
    J Med Virol; 2011 Jan; 83(1):5-9. PubMed ID: 21108333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the epidemiology and clinical presentation of seasonal influenza A and 2009 pandemic influenza A (H1N1) in Guatemala.
    Lindblade KA; Arvelo W; Gray J; Estevez A; Frenkel G; Reyes L; Moscoso F; Moir JC; Fry AM; Olsen SJ
    PLoS One; 2010 Dec; 5(12):e15826. PubMed ID: 21209850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pandemic Influenza A (H1N1) 2009 in India: duration of virus shedding in patients under antiviral treatment.
    Gandhoke I; Rawat DS; Rai A; Khare S; Ichhpujani RL
    Indian J Med Microbiol; 2011; 29(1):37-41. PubMed ID: 21304193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral shedding in Chinese young adults with mild 2009 H1N1 influenza.
    Jia N; Gao Y; Suo JJ; Xie LJ; Yan ZQ; Xing YB; He L; Liu YX
    Chin Med J (Engl); 2011 May; 124(10):1576-9. PubMed ID: 21740820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and comparison of molecular assays for the rapid detection of the pandemic influenza A (H1N1) 2009 virus.
    Lam WY; Leung TF; Lee N; Cheung JL; Yeung AC; Ho YI; Chan RC; Fung KS; Barr IG; Hui DS; Sung JJ; Chan PK
    J Med Virol; 2010 Apr; 82(4):675-83. PubMed ID: 20166184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pandemic influenza A(H1N1) 2009: molecular characterisation and duration of viral shedding in intensive care patients in Bordeaux, south-west France, May 2009 to January 2010.
    Malato L; Llavador V; Marmier E; Youssef J; Balick Weber C; Rozé H; Bessede E; Fleury HJ
    Euro Surveill; 2011 Jan; 16(4):. PubMed ID: 21284922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prior infections with seasonal influenza A/H1N1 virus reduced the illness severity and epidemic intensity of pandemic H1N1 influenza in healthy adults.
    Couch RB; Atmar RL; Franco LM; Quarles JM; Niño D; Wells JM; Arden N; Cheung S; Belmont JW
    Clin Infect Dis; 2012 Feb; 54(3):311-7. PubMed ID: 22075792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.